Artemisinin-based combination therapies (ACTs) are proven effective first-line treatment against uncomplicated malaria and are the current recommendation of WHO. ACTs have the potential to mitigate the emergence of mutant Plasmodium species capable of subverting the effectiveness of antimalarial treatment by pairing fast-acting artimisinins with partner drugs with longer half-lives.

CLICK HERE TO CONTINUE